355 related articles for article (PubMed ID: 32507488)
1. Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.
Moinuddin O; Sathrasala S; Jayasundera KT; Branham KH; Chang EY; Qian CX; Recchia FM; Fahim AT; Besirli CG
Ophthalmol Retina; 2021 Jan; 5(1):86-96. PubMed ID: 32507488
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum, genetic associations and management outcomes of Coats-like exudative retinal vasculopathy in autosomal recessive retinitis pigmentosa.
Magliyah M; Alshamrani AA; Schatz P; Taskintuna I; Alzahrani Y; Nowilaty SR
Ophthalmic Genet; 2021 Apr; 42(2):178-185. PubMed ID: 33441055
[No Abstract] [Full Text] [Related]
3. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
4. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
[TBL] [Abstract][Full Text] [Related]
6. Ocular findings and treatment of a young boy with Coats’ plus.
Yannuzzi NA; Tzu JH; Ko AC; Hess DJ; Cristian I; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(5):462-5. PubMed ID: 25197929
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
8. [Retinal exudative disease in childhood: Coats' disease and familial exudative vitreoretinopathy (FEVR)].
Joussen AM; Gordes RS; Heußen FA; Müller B
Klin Monbl Augenheilkd; 2013 Sep; 230(9):902-13. PubMed ID: 23986189
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study.
Nishiguchi KM; Ikeda Y; Fujita K; Kunikata H; Akiho M; Hashimoto K; Hosono K; Kurata K; Koyanagi Y; Akiyama M; Suzuki T; Kawasaki R; Wada Y; Hotta Y; Sonoda KH; Murakami A; Nakazawa M; Nakazawa T; Abe T
Ophthalmology; 2019 Nov; 126(11):1557-1566. PubMed ID: 31257036
[TBL] [Abstract][Full Text] [Related]
10. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases.
Dalvin LA; Udyaver S; Lim LS; Mazloumi M; Atalay HT; Khoo CTL; Shields CL
J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):288-296. PubMed ID: 31545862
[TBL] [Abstract][Full Text] [Related]
11. Refining Coats' disease by ultra-widefield imaging and optical coherence tomography angiography.
Rabiolo A; Marchese A; Sacconi R; Cicinelli MV; Grosso A; Querques L; Querques G; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1881-1890. PubMed ID: 28875282
[TBL] [Abstract][Full Text] [Related]
12. INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY.
Lyu J; Zhang Q; Xu Y; Zhang X; Fei P; Zhao P
Retina; 2021 Sep; 41(9):1976-1985. PubMed ID: 34432746
[TBL] [Abstract][Full Text] [Related]
13. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.
Shields JA; Shields CL; Honavar SG; Demirci H
Am J Ophthalmol; 2001 May; 131(5):561-71. PubMed ID: 11336930
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
Kumar K; Raj P; Chandnani N; Agarwal A
Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
[TBL] [Abstract][Full Text] [Related]
15. Coats-like Vasculopathy in Inherited Retinal Disease: Prevalence, Characteristics, Genetics, and Management.
Daich Varela M; Conti GM; Malka S; Vaclavik V; Mahroo OA; Webster AR; Tran V; Michaelides M
Ophthalmology; 2023 Dec; 130(12):1327-1335. PubMed ID: 37544434
[TBL] [Abstract][Full Text] [Related]
16. LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.
Lee J; El-Dairi MA; Tran-Viet D; Mangalesh S; Dandridge A; Jiramongkolchai K; Viehland C; Toth CA
Retina; 2019 Jan; 39(1):98-110. PubMed ID: 29190238
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
[TBL] [Abstract][Full Text] [Related]
19. Coats' disease of adult-onset in 48 eyes.
Rishi E; Rishi P; Appukuttan B; Uparkar M; Sharma T; Gopal L
Indian J Ophthalmol; 2016 Jul; 64(7):518-23. PubMed ID: 27609165
[TBL] [Abstract][Full Text] [Related]
20. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.
Liang T; Peng J; Zhang Q; Zhu X; Xu Y; Zhao P
Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2031-2038. PubMed ID: 32474693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
